A Song Draws Focus on Osteosarcoma Research
By Bertram K. Two days after his death in May, Zach Sobiech’s song “Clouds” became the number one download on iTunes and now has surpassed seven million views on YouTube....
Read More
Rare Mutation Leads to New Insights into Melanoma
A study published recently in Science by Susanne Horn and colleagues is a noteworthy example of hypothesis-driven science done right. It exemplifies how seemingly obscure findings can lead to new...
Read More
Novel Genetic Findings for Myeloproliferative Neoplasms
Dave Hinds is a Principal Scientist in Statistical Genetics. Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. 23andMe is passionate about...
Read More
The Molecular Barcode of Cancer – Targeting Treatment to Patient
Understanding the molecular profile of a cancer cell can help physicians understand which drugs will be effective in treating the cancer.
Read More
A Milestone in Sarcoma Research
Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have – to find the causes...
Read More
23andMe Partnering with Patients
By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I...
Read More
Gene Fusions Point to a New Type of Sarcoma
Sarcoma is a rare form of cancer that is often caused by two genes fusing together but which two genes are involved can be different between different types of sarcoma. A group of French researchers recently discovered a new gene fusion characterizing a type of "Ewing-like" sarcomas.
Read More
Talking about Sarcoma with George Demetri
On a recent visit to 23andMe George Demetri –a physician and scientist who is an unpaid advisor to our Sarcoma research initiative – sat down for a short interview after...
Read More
A Cancer Fighter Gets Personal
It’s hard to picture a more “personalized” approach to medicine than Dr. Ronald Levy’s. Levy, chief of the oncology division at Stanford University’s School of Medicine, has spent his career...
Read More
“50/50” Shows Us the Human Side of Cancer
From the minute it became clear that Adam had cancer, he became a statistic, a diagnosis, a “case study”. The odds -- 50/50 -- didn’t seem fair in the context of his life, but his friend Kyle put it into a different perspective: “Dude, if you were a casino game, you’d have the best odds!” Thus begins Adam’s journey with neurofibrosarcoma, a rare form of spinal cancer, in the surprising and transformative new film "50/50", starring Joseph Gordon-Levitt and Seth Rogen.
Read More